Cost-utility analysis of extensile lateral approach versus sinus tarsi approach in Sanders type II/III calcaneus fractures

Zihua Li, Xinbo Wu, Haichao Zhou, Shaochen Xu, Fajiao Xiao, Hui Huang, Yunfeng YangJournal of Orthopaedic Surgery and Research 2020 · DOI

TL;DR

This study compares the cost-effectiveness of two surgical approaches for calcaneus fractures: the extensile lateral approach (ELA) and the sinus tarsi approach (STA). While both methods yield similar clinical outcomes, STA appears to be a more cost-effective option due to lower expenses for analgesia and internal fixation materials, and potentially less postoperative pain.

What Problem Does This Paper Address?

Calcaneus fractures, particularly displaced intra-articular calcaneus fractures (DIACFs), are common and can lead to significant disability and reduced quality of life. The extensile lateral approach (ELA) has been the gold standard for treating these fractures, offering good visualization for reduction. However, ELA is associated with a notable rate of wound complications. The sinus tarsi approach (STA) has emerged as a less invasive alternative, with some studies suggesting comparable clinical outcomes and fewer wound complications. Despite these advancements, the optimal surgical approach for DIACFs remains debated, especially when considering the economic implications. This paper addresses the need for a cost-utility analysis to guide clinicians in making optimal treatment decisions for Sanders type II/III calcaneus fractures, considering both clinical effectiveness and healthcare costs.

Methods

This was a single-center, retrospective study involving 109 patients diagnosed with Sanders type II/III calcaneus fractures who underwent open reduction and internal fixation (ORIF) via either ELA or STA. The study collected basic demographic and clinical characteristics, clinical outcomes, and healthcare costs.

  • Clinical Outcomes: Assessed using the Visual Analogue Scale (VAS) for pain, the American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot scores for functional outcome, and radiographic measurements of Bohler's angle and Gissane angle. These were measured at various time points before and after surgery.
  • Cost-Utility Analysis (CUA): This involved evaluating the health-related quality of life (HRQOL) using the EuroQol five-dimensional-three levels (EQ-5D-3L) instrument. Quality-adjusted life years (QALYs) were calculated from HRQOL scores and time. The cost-effectiveness was determined by the incremental cost per QALY (ICER).
  • Cost Data: Direct healthcare costs were collected from medical and financial records, including expenses for laboratory and radiographic evaluation, surgery, anesthesia, analgesia, internal fixation materials, and antibiotics. Indirect costs were not included.
  • Statistical Analysis: The Kolmogorov-Smirnov test was used to assess normality. Group differences were compared using Student's t-test or Mann-Whitney U test for continuous variables and chi-square tests for categorical variables. Non-parametric tests were used for longitudinal changes. SPSS 20.0 was used for analysis, with a significance level of P < .05.

Datasets

The study utilized data from 109 patients treated at a single center between January 2013 and October 2018. This retrospective dataset included demographic information, fracture characteristics, surgical details, clinical outcome measures (VAS, AOFAS, radiographic angles), and direct healthcare costs. No new benchmarks were introduced.

Key Insights and Ideas

  • STA as a Cost-Effective Alternative: While both ELA and STA provide comparable clinical outcomes in terms of fracture reduction and functional scores, STA emerges as a more economically favorable option. This is primarily driven by lower expenses in specific categories.
  • Pain and Analgesia Link: The study observed significantly lower VAS scores at 3 and 5 days post-surgery for the STA group. This difference in early postoperative pain likely contributes to the reduced expenditure on analgesics in the STA group, making it a more cost-effective choice in this regard.
  • Internal Fixation Material Costs: A significant difference in the cost of internal fixation materials was noted, with ELA requiring more expensive implants compared to STA. This is a key driver of the overall cost difference between the two approaches.
  • No Significant Difference in Major Clinical Outcomes: Despite the cost differences, the study found no significant differences in AOFAS scores, Bohler's angle, or Gissane angle at final follow-up, suggesting that STA can achieve comparable anatomical reduction and functional recovery to ELA.

Key Results

  • Patient Cohort: 109 patients were included: 62 in the ELA group and 47 in the STA group.
  • Cost Differences: Significant differences were found in the expense of internal fixation materials (ELA: $3289.0 ± 543.9 vs. STA: $2630.6 ± 763.7, P < .001) and analgesia (ELA: $145.8 ± 85.6 vs. STA: $102.9 ± 62.7, P = .008).
  • Pain Scores: VAS scores were significantly lower in the STA group at postoperative 3 days (P < .001) and 5 days (P = .002).
  • Clinical Outcomes: No significant differences were observed in AOFAS scores, Bohler's angle, or Gissane angle between the groups at pre-operation, 3 months, or final follow-up.
  • Cost-Effectiveness: The cost-effectiveness ratios (CERs) were $8766.8 ± 2835.2/QALY for ELA and $7914.9 ± 1822.0/QALY for STA. The incremental cost-effectiveness ratio (ICER) of ELA over STA was $32,110.00/QALY, indicating that ELA is more expensive for a similar gain in QALYs.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: The study is retrospective, and randomized clinical trials (RCTs) are considered more robust for establishing causality.
  • Single-Center Bias: Data was collected from a single center, which may limit generalizability and introduce bias. The sample size, while reasonable, could be larger.
  • Exclusion of Indirect Costs: Indirect costs such as lost productivity, rehabilitation, and further consultations were not included, which could influence the overall economic picture.
  • Limited Fracture Types: The study focused only on Sanders type II/III fractures. Future research could explore other fracture types (Sanders I/IV, malunion, nonunion) and incorporate CUA.
  • Recall Bias: The reliance on patient questionnaires may introduce recall bias.
  • Methodological Variability in CUA: CUA methodologies can vary, potentially impacting comparisons with other studies.

Future work could involve prospective RCTs with a broader scope of calcaneus fractures and a more comprehensive inclusion of indirect costs to provide a more complete cost-utility analysis.

Summary updated

Abstract

5.
BibTeX
@article{li2020cost,
  author = {Zihua Li and Xinbo Wu and Haichao Zhou and Shaochen Xu and Fajiao Xiao and Hui Huang and Yunfeng Yang},
  title = {{Cost-utility analysis of extensile lateral approach versus sinus tarsi approach in Sanders type II/III calcaneus fractures}},
  journal = {Journal of Orthopaedic Surgery and Research},
  year = {2020},
  doi = {10.1186/s13018-020-01963-5},
}
Figure